Back

Influence of cholesterol levels on NSAID-associated risks after myocardial infarction: a nationwide population-based cohort study

26 August 2023 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in myocardial infarction Cardiotoxicity of Drugs ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Mr Mohab Basem Abdallah

Aarhus University, Aarhus (Denmark)

5 More presentations in this session

Presentation thumbnail
Long-term outcomes of beta-blocker use in elderly patients without left ventricular systolic dysfunction after percutaneous coronary intervention for acute myocardial infarction
Assistant Professor J. Choe (Pusan, KR)
Abstract Slides
Presentation thumbnail
The effect of discontinuing long-term beta-blockers following acute myocardial infarction in optimally treated, stable patients without heart failure - a Danish, nationwide cohort study
Doctor A. Halili (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Empagliflozin in patients with myocardial infarction: an updated meta-analysis
Doctor M. Abouzid (Poznan, PL)
Abstract Slides Video
Presentation thumbnail
Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction: data from SGLT2-I AMI PROTECT Registry
Doctor P. Paolisso (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study
Doctor A. Aimo (Pisa, IT)
Abstract Slides

Access the full session

Session thumbnail
Pharmacotherapy in myocardial infarction

The Event

Event poster

ESC Congress 2023

26 August 2023 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular safety of non-steroidal anti-inflammatory drug use for gout: A Danish nationwide case-crossover study
thumbnail
Congress Presentation
Non-steroidal anti-inflammatory drug use after invasive and non-invasive diagnostic procedures for coronary artery disease by the degree of disease: a Danish drug utilization study (2008-2021)
thumbnail
Congress Presentation
Cardiovascular risks of ibuprofen versus naproxen: a target trial emulation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources